Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
NCT ID: NCT05490927
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
90 participants
INTERVENTIONAL
2022-10-13
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers
NCT01811628
Determinants of Smoking Cessation Among Latinos
NCT01008748
SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups
NCT05029362
Social Determinants and Smoking Cessation
NCT01310842
A Focus Group Study to Explore Smoking Triggers and Acceptability of Just-in-time Adaptive Intervent
NCT05231421
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smoking Deprivation
16 hours of smoking abstinence prior to experimental visit.
Microaggression Recall and Relapse Analogue Task
Participants will engage in a microaggression recall task followed by the McKee Experimental Relapse Analogue Task
Smoking as Usual
Smoking as usual prior to experimental visit.
Microaggression Recall and Relapse Analogue Task
Participants will engage in a microaggression recall task followed by the McKee Experimental Relapse Analogue Task
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microaggression Recall and Relapse Analogue Task
Participants will engage in a microaggression recall task followed by the McKee Experimental Relapse Analogue Task
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current regular (daily) cigarette smoking for \>= 1 year
* Current smoking \>= 5 cig/day and biochemically confirmed via carbon monoxide (CO) analysis
* Being self-identified as Hispanic or Latino
* Able to provide written, informed consent
* Endorsement of at least one microaggression experience over the past 6-months
Exclusion Criteria
* Active suicidality
* Currently pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brooke Kauffman
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brooke Y Kauffman, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00003689
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.